• Lymphoma & blood cancers
  • Acute Leukaemia
Name No. Patient Profile Purpose
2215 CL 0301 16-09

Acute Myeloid Leukaemia (AML) with FLT3 Mutation that has returned or is resistant to previous treatment

The purpose of this trial is to determine the clinical benefit of ASP2215 therapy.


  • Lymphoma & blood cancers
  • Acute Leukaemia
Name No. Patient Profile Purpose
Protocol 04-30 15-36

Myelodysplastic Syndrome after failure of drugs called Hypomethylating Agents

The purpose of this trial is to evaluate whether adding the drug rigosertib to the patient’s doctor’s choice (standard of care treatment) works better and is as safe as the doctor’s choice.